Zoledronic acid intravenous infusion 4mg/5mL “Sandoz”, manufactured by Sandoz, contains Zoledronic acid hydrate. This injectable drug, with YJ code 3999423A1087 and standard 100mg bottle (likely a vial for dilution), is prescribed for conditions involving bone resorption like hypercalcemia of malignancy and bone metastases.
Zoledronic acid intravenous infusion 4mg/5mL “Sandoz”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →